TickerFactsScreenerDevelopers

InMed Pharmaceuticals Inc. (INM) — Cost of Revenue

Annual figures by fiscal year, from SEC filings.

2022: $545.9K2023: $2.73M2024: $3.50M2025: $3.24M$3.24M
2022Cost of Revenue (USD)2025
Fiscal YearCost of RevenueChange YoY
2025$3.24M-7.5%
2024$3.50M+28.0%
2023$2.73M+400.6%
2022$545.9K—